S&P 500   3,960.50 (-0.08%)
DOW   33,702.87 (-0.23%)
QQQ   284.46 (+0.21%)
AAPL   144.36 (+1.20%)
MSFT   247.25 (-0.06%)
META   116.81 (+1.28%)
GOOGL   93.79 (+0.09%)
AMZN   89.58 (-0.85%)
TSLA   180.34 (+3.98%)
NVDA   173.14 (+0.84%)
NIO   12.86 (-4.10%)
BABA   92.34 (-1.94%)
AMD   69.67 (-1.14%)
T   19.19 (+0.37%)
MU   55.55 (+0.63%)
CGC   2.95 (-4.53%)
F   13.24 (+0.91%)
GE   82.27 (-1.63%)
DIS   94.09 (+1.66%)
AMC   5.88 (-3.13%)
PYPL   74.22 (+0.00%)
PFE   51.88 (+0.19%)
NFLX   325.48 (+4.91%)
S&P 500   3,960.50 (-0.08%)
DOW   33,702.87 (-0.23%)
QQQ   284.46 (+0.21%)
AAPL   144.36 (+1.20%)
MSFT   247.25 (-0.06%)
META   116.81 (+1.28%)
GOOGL   93.79 (+0.09%)
AMZN   89.58 (-0.85%)
TSLA   180.34 (+3.98%)
NVDA   173.14 (+0.84%)
NIO   12.86 (-4.10%)
BABA   92.34 (-1.94%)
AMD   69.67 (-1.14%)
T   19.19 (+0.37%)
MU   55.55 (+0.63%)
CGC   2.95 (-4.53%)
F   13.24 (+0.91%)
GE   82.27 (-1.63%)
DIS   94.09 (+1.66%)
AMC   5.88 (-3.13%)
PYPL   74.22 (+0.00%)
PFE   51.88 (+0.19%)
NFLX   325.48 (+4.91%)
S&P 500   3,960.50 (-0.08%)
DOW   33,702.87 (-0.23%)
QQQ   284.46 (+0.21%)
AAPL   144.36 (+1.20%)
MSFT   247.25 (-0.06%)
META   116.81 (+1.28%)
GOOGL   93.79 (+0.09%)
AMZN   89.58 (-0.85%)
TSLA   180.34 (+3.98%)
NVDA   173.14 (+0.84%)
NIO   12.86 (-4.10%)
BABA   92.34 (-1.94%)
AMD   69.67 (-1.14%)
T   19.19 (+0.37%)
MU   55.55 (+0.63%)
CGC   2.95 (-4.53%)
F   13.24 (+0.91%)
GE   82.27 (-1.63%)
DIS   94.09 (+1.66%)
AMC   5.88 (-3.13%)
PYPL   74.22 (+0.00%)
PFE   51.88 (+0.19%)
NFLX   325.48 (+4.91%)
S&P 500   3,960.50 (-0.08%)
DOW   33,702.87 (-0.23%)
QQQ   284.46 (+0.21%)
AAPL   144.36 (+1.20%)
MSFT   247.25 (-0.06%)
META   116.81 (+1.28%)
GOOGL   93.79 (+0.09%)
AMZN   89.58 (-0.85%)
TSLA   180.34 (+3.98%)
NVDA   173.14 (+0.84%)
NIO   12.86 (-4.10%)
BABA   92.34 (-1.94%)
AMD   69.67 (-1.14%)
T   19.19 (+0.37%)
MU   55.55 (+0.63%)
CGC   2.95 (-4.53%)
F   13.24 (+0.91%)
GE   82.27 (-1.63%)
DIS   94.09 (+1.66%)
AMC   5.88 (-3.13%)
PYPL   74.22 (+0.00%)
PFE   51.88 (+0.19%)
NFLX   325.48 (+4.91%)
NASDAQ:IART

Integra LifeSciences - IART Stock Forecast, Price & News

$56.16
-0.34 (-0.60%)
(As of 12/9/2022 01:33 PM ET)
Add
Compare
Today's Range
$56.11
$56.73
50-Day Range
$41.79
$56.50
52-Week Range
$40.67
$69.95
Volume
4,745 shs
Average Volume
414,337 shs
Market Capitalization
$4.69 billion
P/E Ratio
27.26
Dividend Yield
N/A
Price Target
$57.38

Integra LifeSciences MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
1.8% Upside
$57.38 Price Target
Short Interest
Bearish
5.98% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.50
Upright™ Environmental Score
News Sentiment
0.98mentions of Integra LifeSciences in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$15,685 Sold Last Quarter
Proj. Earnings Growth
6.36%
From $3.30 to $3.51 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.70 out of 5 stars

Medical Sector

861st out of 1,022 stocks

Surgical & Medical Instruments Industry

85th out of 101 stocks

IART stock logo

About Integra LifeSciences (NASDAQ:IART) Stock

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Receive IART Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Integra LifeSciences and its competitors with MarketBeat's FREE daily newsletter.

IART Stock News Headlines

Integra LifeSciences Shares Surge On Q3 Beat
Integra Lifesciences: Q3 Earnings Insights
Expert Ratings for Integra Lifesciences
Integra LifeSciences Publishes Its Inaugural ESG Report
See More Headlines
Receive IART Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Integra LifeSciences and its competitors with MarketBeat's FREE daily newsletter.

IART Company Calendar

Last Earnings
10/26/2022
Today
12/09/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/22/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:IART
CUSIP
45798520
Employees
3,800
Year Founded
1989

Price Target and Rating

Average Stock Price Forecast
$57.38
High Stock Price Forecast
$75.00
Low Stock Price Forecast
$46.00
Forecasted Upside/Downside
+2.2%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
7 Analysts

Profitability

Net Income
$169.07 million
Pretax Margin
12.87%

Debt

Sales & Book Value

Annual Sales
$1.54 billion
Cash Flow
$4.75 per share
Book Value
$19.89 per share

Miscellaneous

Free Float
80,010,000
Market Cap
$4.69 billion
Optionable
Optionable
Beta
1.18

Social Links


Key Executives

  • Mr. Jan De Witte (Age 58)
    Pres, CEO & Director
    Comp: $899.08k
  • Ms. Carrie L. Anderson (Age 53)
    Exec. VP, CFO & Treasurer
    Comp: $1.06M
  • Mr. Robert T. Davis Jr. (Age 63)
    Exec. VP & Pres of Tissue Technologies
    Comp: $975.6k
  • Mr. Michael J. McBreenMr. Michael J. McBreen (Age 56)
    Exec. VP & Pres of Codman Specialty Surgical
    Comp: $855.88k
  • Mr. Jeffrey  MosebrookMr. Jeffrey Mosebrook (Age 46)
    Sr. VP, Principal Accounting Officer & Corp. Controller
  • Dr. Kenneth E. Burhop Ph.D. (Age 68)
    Corp. VP & Chief Scientific Officer
  • Mr. William Compton
    Chief Information Officer & Corp. VP
  • Mr. Eric Ian SchwartzMr. Eric Ian Schwartz (Age 53)
    Exec. VP, Chief Legal Officer & Sec.
  • Laurene Isip
    VP of Global Corp. Communications & PR
  • Ms. Maria Platsis
    Sr. VP of Corp. Devel.













IART Stock - Frequently Asked Questions

Should I buy or sell Integra LifeSciences stock right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Integra LifeSciences in the last twelve months. There are currently 1 sell rating, 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" IART shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in IART, but not buy additional shares or sell existing shares.
View IART analyst ratings
or view top-rated stocks.

What is Integra LifeSciences' stock price forecast for 2023?

7 Wall Street research analysts have issued 12-month price objectives for Integra LifeSciences' stock. Their IART share price forecasts range from $46.00 to $75.00. On average, they predict the company's stock price to reach $57.38 in the next year. This suggests a possible upside of 1.5% from the stock's current price.
View analysts price targets for IART
or view top-rated stocks among Wall Street analysts.

How have IART shares performed in 2022?

Integra LifeSciences' stock was trading at $66.99 on January 1st, 2022. Since then, IART shares have decreased by 15.7% and is now trading at $56.50.
View the best growth stocks for 2022 here
.

When is Integra LifeSciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 22nd 2023.
View our IART earnings forecast
.

How were Integra LifeSciences' earnings last quarter?

Integra LifeSciences Holdings Co. (NASDAQ:IART) issued its quarterly earnings results on Wednesday, October, 26th. The life sciences company reported $0.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.72 by $0.14. The life sciences company earned $385.19 million during the quarter, compared to analysts' expectations of $377.79 million. Integra LifeSciences had a net margin of 11.05% and a trailing twelve-month return on equity of 16.41%.

When did Integra LifeSciences' stock split?

Shares of Integra LifeSciences split on Tuesday, January 3rd 2017. The 2-1 split was announced on Thursday, December 22nd 2016. The newly minted shares were issued to shareholders after the closing bell on Wednesday, December 21st 2016. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

What guidance has Integra LifeSciences issued on next quarter's earnings?

Integra LifeSciences updated its fourth quarter 2022 earnings guidance on Wednesday, November, 2nd. The company provided EPS guidance of $0.87-$0.91 for the period, compared to the consensus earnings per share estimate of $0.88. The company issued revenue guidance of $391.00 million-$403.00 million, compared to the consensus revenue estimate of $403.50 million.

What is Peter J. Arduini's approval rating as Integra LifeSciences' CEO?

173 employees have rated Integra LifeSciences Chief Executive Officer Peter J. Arduini on Glassdoor.com. Peter J. Arduini has an approval rating of 74% among the company's employees.

What other stocks do shareholders of Integra LifeSciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Integra LifeSciences investors own include Boeing (BA), NVIDIA (NVDA), AbbVie (ABBV), Adobe (ADBE), Advanced Micro Devices (AMD), Gilead Sciences (GILD), Intel (INTC), Marvell Technology (MRVL), Alexion Pharmaceuticals (ALXN) and Abbott Laboratories (ABT).

What is Integra LifeSciences' stock symbol?

Integra LifeSciences trades on the NASDAQ under the ticker symbol "IART."

Who are Integra LifeSciences' major shareholders?

Integra LifeSciences' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (8.30%), Eaton Vance Management (5.05%), Cooke & Bieler LP (3.27%), Alliancebernstein L.P. (3.01%), Dimensional Fund Advisors LP (1.53%) and Fisher Asset Management LLC (0.69%). Insiders that own company stock include Eric Schwartz, Glenn Coleman, Jeffrey Mosebrook, Lisa Evoli, Michael J Mcbreen, Peter J Arduini, Raymond G Murphy, Richard E Caruso, Stuart Essig and Tru St Partnership, LP.
View institutional ownership trends
.

How do I buy shares of Integra LifeSciences?

Shares of IART stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Integra LifeSciences' stock price today?

One share of IART stock can currently be purchased for approximately $56.50.

How much money does Integra LifeSciences make?

Integra LifeSciences (NASDAQ:IART) has a market capitalization of $4.72 billion and generates $1.54 billion in revenue each year. The life sciences company earns $169.07 million in net income (profit) each year or $2.06 on an earnings per share basis.

How many employees does Integra LifeSciences have?

The company employs 3,800 workers across the globe.

Does Integra LifeSciences have any subsidiaries?
The following companies are subsidiares of Integra LifeSciences: ACell Inc, ACell Inc., Arkis BioSciences, Arkis Biosciences Inc., Ascension Orthopedics Inc., Ascension Orthopedics Limited, BIMECO Inc., BioD LLC, BioDlogics LLC, BioRecovery LLC, CardioDyne Inc., Cathtec Incorporated, Caveangle Limited, Codman Neuro, Confluent Surgical, Confluent Surgical Inc., Derma First Aid Products Inc., Derma Sciences, Derma Sciences Canada Inc., Derma Sciences Europe Limited, Derma Sciences Inc., EndoSolutions Inc., Fiber Imaging Technologies Inc., GMS Gesellschaft für medizinische Sondentechnik mbH, ILS Financing (Ireland) Limited, ILS Financing Corporation, ILS Services Switzerland Ltd., ILS Surgical Investments LLC, INS Sweden AB, Integra Burlington MA Inc., Integra CI Inc., Integra Canada ULC, Integra Euro Holdings Inc., Integra France Holdings SAS, Integra German Holdings GmbH, Integra GmbH, Integra Japan K.K., Integra LS (Benelux) NV, Integra LS Mexico S. DE R. L. DE C.V., Integra LifeSciences (Canada) Holdings Inc., Integra LifeSciences (Ireland) Limited, Integra LifeSciences (Shanghai) Co. Ltd., Integra LifeSciences Austria GmbH, Integra LifeSciences Brazil Ltda., Integra LifeSciences Corporation, Integra LifeSciences Enterprises LLLP, Integra LifeSciences Financing (Cyprus) Limited, Integra LifeSciences Italy S.r.l., Integra LifeSciences Middle East FZ-LLC, Integra LifeSciences Production Corporation, Integra LifeSciences Sales LLC, Integra LifeSciences Services (France) SAS, Integra LifeSciences Shared Services (Ireland) Limited, Integra LifeSciences Singapore Pte. Ltd., Integra LifeSciences Spain S.L., Integra LifeSciences Switzerland Sárl, Integra Luxtec Inc., Integra ME GmbH, Integra MicroFrance SAS, Integra NeuroSciences (International) Inc., Integra NeuroSciences Holdings (UK) Limited, Integra NeuroSciences Holdings B.V., Integra NeuroSciences Implants (France) SAS, Integra NeuroSciences Limited, Integra Neurosciences, Integra Neurosciences Pty Ltd. (AUS), Integra Neurosciences Pty Ltd. (NZ), Integra Receivables LLC, Integra Sales Inc., Integra Selector LLC, Integra Switzerland Holdings Sarl, Integra York PA Inc., IsoTis NV, IsoTis T.E. Facility B.V., J. Jamner Surgical Instruments Inc., Jarit GmbH, Kinetikos Medical, Koby Ventures II L.P. dba Metasurg, LXU Healthcare Inc. - Medical Specialty Products, MedEfficiency Inc., Medtronic Xomed Instrumentation SAS, Miltex, Minnesota Scientific Inc., Nantong Derma Medical Products Co. Ltd., Newdeal Inc., Newdeal SAS, Omni-Tract, Precise Dental Holding Corp., Precise Dental Internacional S.A. de C.V., Precise Dental Products Ltd., Precision Dental International Inc., Rebound Therapeutics, Rebound Therapeutics Corporation, Spembly Cryosurgery Limited, Spembly Medical Limited, TEI Biosciences (UK) Limited, TEI Biosciences Inc., TEI Biosciences Inc., TEI Medical Inc., TGX Medical Systems, TGX Medical Systems LLC, Tarsus Medical Inc., Tarsus Medical Inc., Tekmed Instruments S.p.A, Theken Disc, Theken Spine, and Therics.
Read More
How can I contact Integra LifeSciences?

Integra LifeSciences' mailing address is 311 ENTERPRISE DRIVE, PLAINSBORO NJ, 08536. The official website for the company is www.integralife.com. The life sciences company can be reached via phone at (609) 275-0500, via email at ir@integralife.com, or via fax at 609-750-4277.

This page (NASDAQ:IART) was last updated on 12/9/2022 by MarketBeat.com Staff